Author

Juan Maria Vázquez Morón

TOFACITINIB IN ULCERATIVE COLITIS: SHORT TERM OUTCOMES IN REAL WORLD EXPERIENCE IN THE SOUTH OF SPAIN
TOFACITINIB IN ULCERATIVE COLITIS: SHORT TERM OUTCOMES IN REAL WORLD EXPERIENCE IN THE SOUTH OF SPAIN

Juan Maria Vázquez Morón  et al.

INCIDENCE AND EVOLUTION OF SARS-COV2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN SOUTHERN SPAIN (ANDALUSIA)
INCIDENCE AND EVOLUTION OF SARS-COV2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN SOUTHERN SPAIN (ANDALUSIA)

Juan Maria Vázquez Morón  et al.

EFFECTIVENESS OF USTEKINUMAB DOSE ESCALATION IN CROHN’S DISEASE PATIENTS WITH INSUFFICIENT RESPONSE TO STANDARD-DOSE SUBCUTANEOUS MAINTENANCE THERAPY: AN OBSERVATIONAL MULTICENTRE STUDY
EFFECTIVENESS OF USTEKINUMAB DOSE ESCALATION IN CROHN’S DISEASE PATIENTS WITH INSUFFICIENT RESPONSE TO STANDARD-DOSE SUBCUTANEOUS MAINTENANCE THERAPY: AN OBSERVATIONAL MULTICENTRE STUDY

Juan Maria Vázquez Morón  et al.

SAFETY OF INFLAMMATORY BOWEL DISEASE DRUGS DURING PREGNANCY AND BREASTFEEDING: MOTHERS AND BABIES’ OUTCOMES (DUMBO REGISTRY)
SAFETY OF INFLAMMATORY BOWEL DISEASE DRUGS DURING PREGNANCY AND BREASTFEEDING: MOTHERS AND BABIES’ OUTCOMES (DUMBO REGISTRY)

Juan Maria Vázquez Morón  et al.

Item 1 - 4 / 4
1